Suppr超能文献

一种亲骨剂DO2A2P的反式和顺式异构体的对比研究。

A comparative study of trans- and cis-isomers of a bone-seeking agent, DO2A2P.

作者信息

Hao Guiyang, Liu Wei, Hassan Gedaa, Öz Orhan K, Kovacs Zoltan, Sun Xiankai

机构信息

Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Institute of Crystal Materials, Shandong University, Jinan, Shandong, China.

出版信息

Bioorg Med Chem Lett. 2015 Feb 1;25(3):571-4. doi: 10.1016/j.bmcl.2014.12.016. Epub 2014 Dec 13.

Abstract

The macrocyclic bone-seeking agent, DO2A2P, bears a cyclen core and two pairs of peripheral phosphonate and carboxylate groups. The geometric disposition of the peripheral functionalities gives arise to a pair of geometric isomers: cis-DO2A2P and trans-DO2A2P. In order to compare the biological behavior of the isomer pair, cis-DO2A2P was synthesized. Both isomers were successfully radiolabeled with (177)Lu, which might potentiate their applications in both radiotherapy and imaging of bone diseases. Through a set of biological assays including the hydroxyapatite binding, in vitro stability, and in vivo distribution, we demonstrated that the geometric pair of DO2A2P had virtually identical biological properties.

摘要

大环亲骨剂DO2A2P具有一个环烯核心以及两对外围膦酸酯和羧酸酯基团。外围官能团的几何排布产生了一对几何异构体:顺式-DO2A2P和反式-DO2A2P。为了比较这对异构体的生物学行为,合成了顺式-DO2A2P。两种异构体均成功用(177)Lu进行了放射性标记,这可能会增强它们在骨疾病放疗和成像中的应用。通过一系列生物学试验,包括羟基磷灰石结合、体外稳定性和体内分布,我们证明了DO2A2P的几何异构体对具有几乎相同的生物学特性。

相似文献

1
A comparative study of trans- and cis-isomers of a bone-seeking agent, DO2A2P.
Bioorg Med Chem Lett. 2015 Feb 1;25(3):571-4. doi: 10.1016/j.bmcl.2014.12.016. Epub 2014 Dec 13.
4
Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
Nucl Med Biol. 2009 Aug;36(6):591-603. doi: 10.1016/j.nucmedbio.2009.03.006.
7
In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs.
Mol Pharm. 2018 Nov 5;15(11):4995-5004. doi: 10.1021/acs.molpharmaceut.8b00606. Epub 2018 Sep 28.
9
Preparation of clinical-scale Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling, and freeze-dried kit formulation.
J Labelled Comp Radiopharm. 2017 May 15;60(5):234-241. doi: 10.1002/jlcr.3493. Epub 2017 Mar 23.
10
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
J Nucl Med. 2015 Aug;56(8):1169-76. doi: 10.2967/jnumed.115.158550. Epub 2015 Jun 18.

本文引用的文献

1
Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Nucl Med Biol. 2011 Oct;38(7):1011-8. doi: 10.1016/j.nucmedbio.2011.02.015. Epub 2011 Apr 21.
2
Bisphosphonates as radionuclide carriers for imaging or systemic therapy.
Mol Biosyst. 2011 Nov;7(11):2950-66. doi: 10.1039/c1mb05242j. Epub 2011 Aug 30.
4
PET with non-standard nuclides.
Curr Top Med Chem. 2010;10(11):1096-112. doi: 10.2174/156802610791384289.
5
An osteoclast-targeting agent for imaging and therapy of bone metastasis.
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4789-93. doi: 10.1016/j.bmcl.2008.07.092. Epub 2008 Jul 27.
7
Bifunctional chelates for metal nuclides.
Q J Nucl Med Mol Imaging. 2008 Jun;52(2):166-73. Epub 2007 Nov 28.
10
Metastasis to bone: causes, consequences and therapeutic opportunities.
Nat Rev Cancer. 2002 Aug;2(8):584-93. doi: 10.1038/nrc867.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验